Skip to content
DataLookout
Menu

NCT06644430

Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 1 year 6 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Dec 30, 2026
    • Eligibility criteria shortened, about 27 words
  2. Minor Study completion date: Oct 30, 2025 to Dec 30, 2025
    • Start date changed from estimate of Nov 4, 2024 to Oct 4, 2024
    v3
  3. Minor Start date: Oct 20, 2024 to Nov 4, 2024v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Progression-Free-Survival
Timeframe: 12 months

Secondary (2)

Overall survival (OS)
Objective response rate (ORR)

Arms and interventions

Ablation+system group

Participants received ablation of plumonary combined systemic therapy

System group

Participants received systemic therapy

Procedures: Ablation

Drugs: system therapy

Sites

1 site in 1 country

  • Chinese PLA General hospitalBeijing, Beijing Municipality, China